Arzeda is a synthetic biology company that designs novel proteins and enzymes using computational protein design, machine learning, and experimental engineering to enable biocatalysis and biomanufacturing. The company provides a platform for accelerating discovery and optimization of enzymes and pathways for industrial chemicals, specialty ingredients, and other bio-based products, partnering with manufacturers to reduce development time and improve production efficiency.
Arzeda LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Arzeda had 79 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Arzeda had 9,568 followers as of October 26, 2026. The number of followers increased by 58 (0.61%) week-over-week.
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Oct 30, 2025 | Investment | $7.80M | ― |
| Investor Name | Funding Round |
|---|---|
| National Science Foundation | Investment |
A snapshot of private companies similar to Arzeda, helping you discover and navigate related company profiles.